New guidance from health technology assessment (HTA) agency NICE backs the use of Wainzua (eplontersen) to treat stage 1 or 2 ...

“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

Advanz won a temporary reprieve in September after the General Court of the European Union ordered a suspension of the EC's ...

Trump has nominated Dr Jay Bhattacharya, a 56-year-old physician and health economist at Stanford University School of ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...

The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients ...

Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders ...

Celebrating 10 years as the definitive platform for the NK community, the flagship Innate Killer Summit will unite ...

Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory ...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development, quality ...